Ryan Hurt, MD
Internal Medicine · Rochester, MNNPI 1578603163
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Every reported general payment came from a single manufacturer, Nestle Healthcare Nutrition Inc.. 2023 is the largest year on record at $6,540, 2.2 times the $3,000 reported in 2020. Among internal medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $484.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nestle Healthcare Nutrition Inc.$19K
Across 17 payments — averaging $9887.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zealand Pharma A/s$148K
- Pfizer$20K
What the payments were for
- Consulting fees$10,94258%
- Speaking & faculty fees$3,75020%
- Travel & lodging$2,30712%
- Food & beverage$1,87810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nestle Healthcare Nutrition Inc. | 39 | $18,877 |
How this compares
$18,877 in reported general payments places this provider in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Guanfacine Hcl | 15 | $508 |
| Rosuvastatin Calcium | 14 | $156 |
| Amlodipine Besylate | 11 | $147 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rochester
- Gregory PolandRochester$494K
- Ekta KapoorRochester$55K
- Luke SeaburgRochester$55K
- Robert PignoloRochester$52K
- Ilya ShadrinRochester$35K
- Brian JonesRochester$34K
- Jody OlsonRochester$26K
- James HaysRochester$23K
- Amit SoodRochester$22K
- Larissa Fujii-LauRochester$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.